title: Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats.
abstract: Prior studies suggest that prolactin (PRL) stimulates release of dopamine (DA) from tuberoinfundibular dopaminergic (TIDA) neurons. In the present study, the time course over which PRL exerts its effects on all three populations of neuroendocrine dopaminergic (DAergic) neuron populations [TIDA, tuberohypophyseal (THDA) and periventricular-hypophyseal (PHDA)] was determined. Ten days following ovariectomy (OVX), groups of female rats were injected either with 15 microg of ovine PRL (oPRL) or saline at 0900 h. Rats were decapitated every 30 min from 0830 h-1100 h and hourly from 1200 h-1500 h. Trunk blood was assayed for rat PRL (rPRL) and oPRL using species-specific radioimmunoassays (RIAs). The concentration of DA and 3,4-dihydroxyphenylacetic acid (DOPAC) in the median eminence (ME), as well as the anterior (AL), intermediate (IL) and neural (NL) lobes of the pituitary gland were determined by HPLC-EC. The concentration of rPRL in oPRL-treated animals, compared to saline-treated animals, was diminished by 1000 h and again between 1200 h-1500 h. DOPAC/DA ratio, an indicator of dopaminergic neuronal activity, increased spontaneously in the ME, IL, and NL during the afternoon in OVX rats. In animals injected with oPRL at 0900 h, the DOPAC/DA ratio increased in the ME, IL and NL within 1 h. Moreover, a secondary increase in the DOPAC/DA ratio in the IL and NL occurred during the afternoon in oPRL-treated rats. However, the second increase of DA turnover present in the ME of control animals never occurred in oPRL-treated animals. Furthermore, there were two increases in the concentration of DA in the AL: the first coincided with the increased turnover of DA in all three terminal areas and the second with increased DA turnover in the IL and NL. These data suggest that all three populations of hypothalamic neuroendocrine DAergic neurons are activated by PRL and that PHDA/THDA neurons have a second 'delayed' activation.
authors.affiliation: Program in Neuroscience, Department of Biological Science, Florida State University, Tallahassee, FL 32306-4340, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: DeMaria
authors.forename: A A
authors.initials: AA
authors.lastname: Lerant
authors.forename: M E
authors.initials: ME
authors.lastname: Freeman
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D002940:Circadian Rhythm; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000502:physiology*; D008473:Median Eminence / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D010052:Ovariectomy; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000502:physiology*; D010904:Pituitary Gland, Posterior / Q000187:drug effects / Q000502:physiology*; D011388:Prolactin / Q000097:blood / Q000494:pharmacology* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012756:Sheep
chemical_list: D015102:3,4-Dihydroxyphenylacetic Acid; D011388:Prolactin; D004298:Dopamine